Full Text View
Tabular View
No Study Results Posted
Related Studies
Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
This study is ongoing, but not recruiting participants.
Study NCT00879606   Information provided by Altor Bioscience Corporation

First Received on April 8, 2009.   Last Updated on March 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sepsis
Acute Lung Injury
Acute Respiratory Distress Syndrome
Additional conditions recognized in this trial
Lung Injury
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn
Toxemia
More general conditions related to this trial
Infant, Newborn, Diseases
Infant, Premature, Diseases
Infection
Inflammation
Lung Diseases
Pathologic Processes
Respiration Disorders
Respiratory Tract Diseases
Systemic Inflammatory Response Syndrome
Thoracic Injuries
Wounds and Injuries
Interventions listed in this trial
ALT-836
Placebo
Sponsors listed in this trial
Altor Bioscience Corporation
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services